These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 123839)

  • 1. Investigation on Huntington's disease. III. Biochemical observations, a possibly predictive test?
    Shokeir MH
    Clin Genet; 1975 Apr; 7(4):354-60. PubMed ID: 123839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum dopamine-beta-hydroxylase activity in patients with Huntington's chorea and Parkinson's disease.
    Lieberman AN; Freedman LS; Goldstein M
    Lancet; 1972 Jan; 1(7742):153-4. PubMed ID: 4109012
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma dopamine-beta-hydrozylase in Huntington's chorea.
    Mattsson B; Wetterberg L; Ross SB
    Acta Psychiatr Scand Suppl; 1974; 255():237-44. PubMed ID: 4282555
    [No Abstract]   [Full Text] [Related]  

  • 4. Endogenous sodium-potassium ATPase inhibition related biochemical cascade in trisomy 21 and Huntington's disease: neural regulation of genomic function.
    Kumar AR; Kurup PA
    Neurol India; 2002 Jun; 50(2):174-80. PubMed ID: 12134182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum dopamine-beta-hydroxylase, glutamic acid decarboxylase and 1-aromatic amino acid decarboxylase in involuntary movement disorders (author's transl)].
    Nakamura S; Miyata S; Kameyama M
    Rinsho Shinkeigaku; 1979 Aug; 19(8):511-4. PubMed ID: 159153
    [No Abstract]   [Full Text] [Related]  

  • 6. [Endorphins and neurotensin in Huntington chorea].
    Nikol'skaia NN; Korshunova TS; Nikitenko NIu; Ivanova-Smolenskaia IA
    Vopr Med Khim; 1996; 42(3):263-7. PubMed ID: 9139462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical studies in Huntington's chorea. 3. Aminoacids in serum and urine.
    Bruyn GW
    Psychiatr Neurol Neurochir; 1966; 69(2):139-42. PubMed ID: 4225277
    [No Abstract]   [Full Text] [Related]  

  • 8. Dopamine-beta-hydroxylase effectors in neuroblastoma.
    Brewster MA; Berry DH
    Ann Clin Lab Sci; 1979; 9(4):343-6. PubMed ID: 485096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dopamine beta hydroxylase. Value and limits of its study in neurology].
    Miras Portugal MT; Aunis D; Mandel P; Warter JM; Coquillat G; Collard M; Rohmer F
    Rev Neurol (Paris); 1976 Jun; 132(6):383-9. PubMed ID: 940970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Huntington's disease: A transcriptional report card from the peripheral blood: can it measure disease progression in Huntington's disease?
    Tabchy A; Housman D
    Eur J Hum Genet; 2006 Jun; 14(6):649-50. PubMed ID: 16538227
    [No Abstract]   [Full Text] [Related]  

  • 11. At risk for Huntington's disease: who should know what and when?
    Rosenfeld A
    Hastings Cent Rep; 1984 Jun; 14(3):5-8. PubMed ID: 6086548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A genetic study of red cell osmotic fragility in Huntington's disease.
    McCormack MK; Lazzarini A; Toke D; Lepore F
    Am J Med Genet; 1984 May; 18(1):5-11. PubMed ID: 6234801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Activity of the enzymes participating in the metabolism of biogenic amines in patients with depressive syndromes. III. Dopamine beta-hydroxylase (DBH) activity in the serum].
    Matsumoto H; Pacyna M; Pietruszewska I; Lewicka-Wysocka H
    Psychiatr Pol; 1983; 17(1):19-23. PubMed ID: 6622589
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of polymorphous DNA probes in the study of French families with Huntington's chorea].
    Lucotte G; Berriche S; Burckel A; Turpin JC
    Rev Neurol (Paris); 1990; 146(4):303-5. PubMed ID: 1972803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Huntington's disease: N-methyl-D-aspartate receptor coagonist glycine is increased in platelets.
    Reilmann R; Rolf LH; Lange HW
    Exp Neurol; 1997 Apr; 144(2):416-9. PubMed ID: 9168841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic discrimination: Huntington's disease and the Americans with Disabilities Act.
    Gin BR
    Columbia Law Rev; 1997 Jun; 97(5):1406-34. PubMed ID: 10175166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metabolic disorders in Huntington's chorea].
    Insarova NG; Korshunova TS; Mzhel'skaia TI; Borisova TV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(4):489-95. PubMed ID: 148828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychological functioning before predictive testing for Huntington's disease: the role of the parental disease, risk perception, and subjective proximity of the disease.
    Decruyenaere M; Evers-Kiebooms G; Boogaerts A; Cassiman JJ; Cloostermans T; Demyttenaere K; Dom R; Fryns JP
    J Med Genet; 1999 Dec; 36(12):897-905. PubMed ID: 10593997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
    Huot P; Lévesque M; Parent A
    Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines for the molecular genetics predictive test in Huntington's disease. International Huntington Association (IHA) and the World Federation of Neurology (WFN) Research Group on Huntington's Chorea.
    Neurology; 1994 Aug; 44(8):1533-6. PubMed ID: 8058167
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.